HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 30 July 2012

HTA methods digest

If you haven’t had time to catch-up on all the methods papers published in the last couple of months, here’s our take on the most important covering all aspects of HTA.

Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach.
Hawkins N, Richardson G, Sutton AJ, Cooper NJ, Griffiths C, Rogers A, Bower P.
Health Econ. 2012 Jun;21(6):742-56. doi: 10.1002/hec.1741. Epub 2011 Jul 28.

The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies.
Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, Mierzwinski-Urban M, Clifford T, Hutton B, Rabb D.
Int J Technol Assess Health Care. 2012 Apr;28(2):138-44.

Bayesian meta-analysis on medical devices: application to implantable cardioverter defibrillators.
Youn JH, Lord J, Hemming K, Girling A, Buxton M.
Int J Technol Assess Health Care. 2012 Apr;28(2):115-24.

Accounting for biases when linking empirical studies and simulation models.
Goldhaber-Fiebert JD.
Med Decis Making. 2012 May-Jun;32(3):397-9.

Comparison of FACT- and EQ-5D-based utility scores in cancer.
Pickard AS, Ray S, Ganguli A, Cella D.
Value Health. 2012 Mar-Apr;15(2):305-11. Epub 2012 Feb 2.

Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis: An Application of Bayesian Methods for Evidence Synthesis in a Markov Model.
Nguyen CM, Bounthavong M, Mendes MA, Christopher ML, Tran JN, Kazerooni R, Morreale AP.
Pharmacoeconomics. 2012 Jul 1;30(7):575-93.